Cytosorbents (CTSO) Gross Margin (2011 - 2026)
Cytosorbents' (CTSO) quarterly Gross Margin came in at 69.16% in Q1 2026, down 197.0% YoY from 71.29% in Q1 2025, and down 6.15% on a QoQ basis from 73.68% in Q4 2025.
Cytosorbents (CTSO) Gross Margin (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of Gross Margin data on file, last reported at 69.16% in Q1 2026.
- Quarterly Gross Margin fell 197.0% year-over-year to 69.16% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 71.01% (up 245.0% YoY) and the FY2025 annual result came in at 71.48%, up 156.0% from the prior year.
- Gross Margin eased to 69.16% in Q1 2026, from 73.68% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 76.46% in Q1 2024 to a low of 44.6% in Q3 2022.
- A 5-year average of 65.82% and a median of 68.35% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin plunged 3017 bps — and 2023, when it surged 1904 bps.
- Tracing CTSO's Gross Margin over 5 years: stood at 61.31% in 2022, then decreased by 0 bps to 61.27% in 2023, then increased by 12 bps to 68.35% in 2024, then rose by 8 bps to 73.68% in 2025, then retreated by 6 bps to 69.16% in 2026.
- The last three Gross Margin figures came in at 69.16% (Q1 2026), 73.68% (Q4 2025), and 70.28% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 45.84% |
| 10 | Cytosorbents | 21.99 Mn | 17.58 Mn | 7.05 Mn | 73.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.18% |
| Mar 31, 2026 | 69.16% |
| Dec 31, 2025 | 73.68% |
| Sep 30, 2025 | 70.28% |
| Jun 30, 2025 | 70.85% |
| Mar 31, 2025 | 71.12% |
| Dec 31, 2024 | 68.35% |
| Sep 30, 2024 | 61.02% |
| Jun 30, 2024 | 73.55% |
| Mar 31, 2024 | 76.46% |
| Dec 31, 2023 | 61.27% |
| Sep 30, 2023 | 63.64% |
| Jun 30, 2023 | 63.89% |
| Mar 31, 2023 | 57.73% |
| Dec 31, 2022 | 61.31% |
| Sep 30, 2022 | 44.60% |
| Jun 30, 2022 | 58.21% |
| Mar 31, 2022 | 73.79% |
| Dec 31, 2021 | 71.04% |
| Sep 30, 2021 | 74.77% |